Stanford Review Rebutts 'Slow AI' Argument on Cancer Research
Merzmensch · x · 2026-08-22
Stanford Tech Review publishes a rebuttal to Emma Pierson's Atlantic essay arguing for slowing AI to avoid societal risks. The author argues that while personal risk-taking is valid, it should not dictate public policy that hampers medical progress. The article notes that AI doesn't need a cinematic cure to save lives—improvements in detection and trial design are already vital. It advocates for targeted safeguards (testing, monitoring) over a broad slowdown that penalizes beneficial applications already governed by clinical oversight.
Related event: Debate Erupts Over Whether Slowing AI Delays Cancer Cures(3 posts)→
More from AGI Musings
- 50% chance of AI recursive self-improvement within 4 years — peterwildeford · 2026-08-24
- LLMs enable 'Small Software': The rise of bespoke tools for one — threepointone · 2026-08-24
- Continual learning should adapt to noisy data, not over-clean it — Shahules786 · 2026-08-24
- The hallucination problem: Confidently wrong LLMs and the scale of fact-checking — ingliguori · 2026-08-24
- OpenAI CEO Criticizes Anthropic: Ceding Control to AI is Misanthropic — ns123abc · 2026-08-24
- Contribution Proof May Replace First-Publisher Priority in Agent Era — schwentker · 2026-08-24